Ticlopidine Alone Versus Ticlopidine Plus Aspirin for Preventing Recurrent Stroke

Eiichi ITO; Akira TAKAHASHI; Hiroko YAMAMOTO; Shigeki KUZUHARA; Shinichiro UCHIYAMA; Mitsuyoshi NAKAJIMA

doi:10.2169/internalmedicine.42.793

Eiichi ITO, Akira TAKAHASHI, Hiroko YAMAMOTO, Shigeki KUZUHARA, Shinichiro UCHIYAMA, Mitsuyoshi NAKAJIMA

著者情報

キーワード: stroke, secondary prevention, ticlopidine, aspirin, combination therapy

ジャーナルフリー

2003 年 42 巻 9 号 p. 793-799

DOI https://doi.org/10.2169/internalmedicine.42.793

詳細

抄録

Objective To compare the efficacy and safety of two antiplatelet regimens, ticlopidine alone (200 mg daily) and ticlopidine (100 mg daily) plus aspirin (81 mg daily), in patients with ischemic stroke from the Tokai district of Japan.
Methods A randomized comparative study was performed from April 1992 until December 1995, with follow-up for an average of 1.59 years (maximum: 0

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）